NON-INVASIVE MONITORING OF FOETAL ANAEMIA IN KELL SENSITIZED PREGNANCY

Authors

  • Zaibun Nisa Department of Obstetrics and Gynaecology, Aga Khan University Hospital, Karachi
  • Sana Sadiq Sheikh Department of Obstetrics and Gynaecology, Aga Khan University Hospital, Karachi

Abstract

We report a case of Kell sensitized pregnancy with good neonatal outcome. Anti-K antibodies were detected in maternal serum in early pregnancy as a part of routine antibody screening test. The middle cerebral artery doppler monitoring and serial titers were carried out to screen for foetal anaemia. Despite of rising antibody titers, serial middle cerebral artery doppler was normal and did not showed foetal anaemia. The pregnancy was carried out till term and patient delivered at 37 weeks of pregnancy with no evidence of foetal anaemia. This case underlines the need of general screening on rare antibodies in all pregnant women and that non-invasive monitoring of foetal anaemia can be done with anti-k titers and middle cerebral artery Doppler.Keywords: Kell, Blood group incompatibility, Irregular antibodies, Noninvasive monitoring

References

de Jonge N, Martens JE, Milani AL, Krijnen JL, van Krimpen C, Ponjee GA. Haemolytic disease of the newborn due to anti-K antibodies. Eur J Obstet Gynecol Reprod Biol 1996;67(1):69–72.

Geifman-Holtzman O, Wojtowycz M, Kosmas E, Artal R. Female alloimmunization with antibodies known to cause hemolytic disease. Obstet Gynecol 1997;89(2):272–5.

Polesky HF. Blood group antibodies in prenatal sera. Results of screening 43,000 individuals. Minn Med 1967;50(4):601–3.

Queenan JT Smith BD, Haber JM, Jeffrey J, Gadow HC. Irregular antibodies in the obstetric patient. Obstet Gynecol 1969;34(6):767–71.

Reid ME, Toy PTCY. Erythrocyte blood groups in transfusion. In: Nathan D, Orkin SH, editor. Hematology of Infancy and Childhood. 5 ed. Philadelphia: WB Saunders; 1998. p. 1761.

Vaughan JI, Warwick R, Letsky E, Nicolini U, Rodeck CH, Fisk NM. Erythropoietic suppression in foetal anaemia because of Kell alloimmunization. Am J Obstet Gynecol 1994;171(1):247–52.

Bowman JM, Pollock JM, Manning FA, Harman CR, Menticoglou S. Maternal Kell blood group alloimmunization. Obstet Gynecol 1992;79(2):239–44.

Caine ME, Mueller-Heubach E. Kell sensitization in pregnancy. Am J Obstet Gynecol 1986;154(1):85–90.

Vaughan JI, Manning M, Warwick RM, Letsky EA, Murray NA, Roberts IAG. Inhibition of erythroid progenitor cells by anti-Kell antibodies in foetal alloimmune anaemia. N Engl J Med 1998;338(12):798–803.

Daniels G, Hadley A, Green CA. Causes of foetal anaemia in hemolytic disease due to anti-K. Transfusion 2003;43(1):115–6.

McKenna DS, Nagaraja HN, O'Shaughnessy R. Management of pregnancies complicated by anti-Kell isoimmunization. Obstet Gynecol 1999;93(5, Part 1):667–73.

van Wamelen DJ, Klumper FJ, De Haas M, Meerman RH, van Kamp IL, Oepkes D. Obstetric history and antibody titer in estimating severity of Kell alloimmunization in pregnancy. Obstet Gynecol 2007;109(5):1093–8.

Van Dongen H, Klumper FJ, Sikkel E, Vandenbussche F, Oepkes D. Non-invasive tests to predict foetal anaemia in Kell alloimmunized pregnancies. Ultrasound Obstet Gynecol 2005;25(4):341–5.

Rimon E, Peltz R, Gamzu R, Yagel S, Feldman B, Chayen B, et al. Management of Kell isoimmunization evaluation of a Doppler guided approach. Ultrasound Obstet Gynecol 2006;28(6):814–20.

Seeho SK, Burton G, Leigh D, Marshall JT, Persson JW, Morris JM. The role of preimplantation genetic diagnosis in the management of severe rhesus alloimmunization: first unaffected pregnancy: case report. Hum Reprod 2005;20(3):697–701

Downloads

Published

2015-06-20